Joined March 2012
First resolution for 2025: I am leaving this platform for good. Find me @bluesky MarcAndre64.bsky.social 🦋
42
It was a true honour to be part of this practice changing study #inmind for RR FL. Main messages in addition to better efficacy…fixed duration w/o excess events after tx stop, no added toxicity, excellent TTNT…works in high risk pts, my best choice for 2L FL. #lymsm #ash24
9
40
3,385
#ASH24 session acknowledging the legacy of Prof. Éliane Gluckman awarded the Wallace H. Coulter award for a lifetime of achievement in cord blood transplantation. Room packed with attendees and excitement in anticipation of the Plenary Session! #womeninmedicine
5
1
27
1,932
André Marc retweeted
Big success for ELI's 10th Workshop on "Lymphoma of immune privilege sites" held last week in Stresa!
2
3
351
Teaching at #ESMOAcademy, @myESMO in Zurich about #Hodgkin. Great audience. My take home: 📣 PET CT at dx and after 2 chemo decide treatment 📣 Limit relapse check-up to 2 years, next focus on late effects 📣 Fertility counseling 📣 BrECADD new standard 📣 Nivo-AVD in elderly?
1
4
23
3,213
O can safely be used in combination with chemotherapy and in maintenance after ASCT as frontline therapy in patients with MCL. ow.ly/PBYz50SFxFu #clinicatrialsandobservations #lymphoidneoplasia
16
30
5,183
👀
Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma ow.ly/2i1Z50SFwC6 #clinicaltrialsandobservations #immunobiologyandimmunotherapy #lymphoidneoplasia
3
13
1,296
Ce 12 juillet, les pilotes de la @PAFofficiel ont laissé leurs alphajets pour venir visiter @HopSaintLouis par le biais de l’association @AssoELLyE. Un elan du cœur pour les patients atteints de lymphome et ceux qui les soignent 🇫🇷❤️ Cc @APHP @c_thieblemont @FenauxP
9
13
1,190
Surprise-surprise :)
EscBEACOPP vs BreCADD - HD21. Embargoed abstract but title says it all. Looks like efficacy is superior. #EHA24 #lymsm
2
5
433
📢 Proud to see this important, timely comment by @DrLauraEsserman & @DougYeeMD just published in @NatureMedicine. I 💯 agree: Science & medical groups should stop holding conferences in anti-choice states. Abortion IS healthcare! #WomensRights Please RT! nature.com/articles/s41591-0…
2
5
886
André Marc retweeted
DESCAR-T strikes again… Largest study on transfusion use post CART led by @HouotRoch out today in @BloodAdvances ⤵️ ashpublications.org/bloodadv… Enjoyed writing the associated commentary with @moh7madhomod! Check it out ⤵️ ashpublications.org/bloodadv… @MSKCancerCenter
2
22
82
7,216
Final Analysis of the Ro-CHOP Trial in T-cell lymphoma: In an exploratory analysis, the median PFS in the centrally reviewed follicular helper T-cell lymphoma subgroup was significantly longer in the Ro-CHOP arm. @JCO_ASCO ascopubs.org/doi/full/10.120…
5
13
1,615
Why some clinical trials cost >$100k per patient in one picture. #mmsm #MedTwitter
2
16
3,038
Célébrez Noël 🎅🏼 en offrant les meilleurs équipements d’activité physique adaptée pour les patients atteints de lymphome! Car oui, la forme physique optimise les résultats thérapeutiques.💪 Un grand merci pour votre générosité. 🎄🎁 Cc @c_thieblemont @Roberta04704608 @APHP
🌟 En cette veille des fêtes, offrez un cadeau qui compte vraiment. ✨ Le Dr @ComeBommier explique comment aider l’@HopSaintLouis @APHP à créer une salle de sport pour les patients luttant contre le cancer et l'incroyable impact de ce projet 🏋️🎁 ➡️ don-hopitaux-nord.aphp.fr/sl…
2
13
15
2,639
It was such an exciting time presenting our data on SYMPATICO trial. It is a milestone achievement for our patients with mantle cell lymphoma in the world!
1
5
1
69
3,698
Finally, analyzing 310 blood samples from 109 patients we found that #PhasEDSeq #MRD better captures relapse risk than functional imaging by PETCT. 12/15
1
2
7
1,214